ID   Ma-25
AC   CVCL_7065
SY   Ma25
DR   BTO; BTO_0004155
DR   cancercelllines; CVCL_7065
DR   Cosmic; 801600
DR   Cosmic; 844840
DR   Cosmic; 876178
DR   Cosmic; 917981
DR   Cosmic; 1047101
DR   Cosmic; 1239921
DR   Cosmic; 2125277
DR   Cosmic; 2668335
DR   IARC_TP53; 11884
DR   IARC_TP53; 28447
DR   Wikidata; Q54903702
RX   PubMed=9393586;
RX   PubMed=10536175;
RX   PubMed=11005564;
RX   PubMed=17332333;
RX   PubMed=19472407;
RX   PubMed=20557307;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>A); ClinVar=VCV000142714; Zygosity=Unspecified (PubMed=10536175; PubMed=20557307).
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
RX   PubMed=9393586; DOI=10.1007/s004320050101;
RA   Shimizu E., Zhao M.-R., Shinohara A., Namikawa O., Ogura T., Masuda N.,
RA   Takada M., Fukuoka M., Sone S.;
RT   "Differential expressions of cyclin A and the retinoblastoma gene
RT   product in histological subtypes of lung cancer cell lines.";
RL   J. Cancer Res. Clin. Oncol. 123:533-538(1997).
//
RX   PubMed=10536175; DOI=10.3892/ijo.15.5.927;
RA   Fujita T., Kiyama M., Tomizawa Y., Kohno T., Yokota J.;
RT   "Comprehensive analysis of p53 gene mutation characteristics in lung
RT   carcinoma with special reference to histological subtypes.";
RL   Int. J. Oncol. 15:927-934(1999).
//
RX   PubMed=11005564; DOI=10.1038/sj.neo.7900094; PMCID=PMC1550293;
RA   Kohno T., Sato T., Takakura S., Takei K., Inoue K., Nishioka M.,
RA   Yokota J.;
RT   "Mutation and expression of the DCC gene in human lung cancer.";
RL   Neoplasia 2:300-305(2000).
//
RX   PubMed=17332333; DOI=10.1158/0008-5472.CAN-06-3339;
RA   Okabe T., Okamoto I., Tamura K., Terashima M., Yoshida T., Satoh T.,
RA   Takada M., Fukuoka M., Nakagawa K.;
RT   "Differential constitutive activation of the epidermal growth factor
RT   receptor in non-small cell lung cancer cells bearing EGFR gene
RT   mutation and amplification.";
RL   Cancer Res. 67:2046-2053(2007).
//
RX   PubMed=19472407; DOI=10.1002/humu.21028; PMCID=PMC2900846;
RA   Blanco R., Iwakawa R., Tang M.-Y., Kohno T., Angulo B., Pio R.,
RA   Montuenga L.M., Minna J.D., Yokota J., Sanchez-Cespedes M.;
RT   "A gene-alteration profile of human lung cancer cell lines.";
RL   Hum. Mutat. 30:1199-1206(2009).
//
RX   PubMed=20557307; DOI=10.1111/j.1349-7006.2010.01622.x; PMCID=PMC11158680;
RA   Iwakawa R., Kohno T., Enari M., Kiyono T., Yokota J.;
RT   "Prevalence of human papillomavirus 16/18/33 infection and p53
RT   mutation in lung adenocarcinoma.";
RL   Cancer Sci. 101:1891-1896(2010).
//